What is LTGO's current stock price?

LTGO (Latigo Biotherapeutics Inc.) is currently trading at $13.01 with a market cap of $782.6M.

What sector is Latigo Biotherapeutics Inc. in?

Latigo Biotherapeutics Inc. (LTGO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.

InvestLog

Back to Market返回行情

LTGO Latigo Biotherapeutics Inc.

NASDAQHealthcare

$13.01-7.34%ClosedMarket Cap: $782.6M

As of 2026-11-05

Why LTGO matters now

Latigo Biotherapeutics Inc. (LTGO) is a US stock in Healthcare. The latest InvestLog snapshot shows $13.01 with -7.34% on the session and $782.6M in market capitalization.

The latest indexable market news headline is "Vertex Built The NaV1.8 Market, Latigo May Be The One To Profit From It" from Seeking Alpha.

Latest News

Vertex Built The NaV1.8 Market, Latigo May Be The One To Profit From ItSeeking Alpha · 2026-10-11

Latigo Biotherapeutics (NASDAQ:LTGO) Hits New 12-Month Low – Here’s WhyDefense World · 2026-10-08

Latigo Biotherapeutics, Inc.’s Quiet Period Will End on September 16th (NASDAQ:LTGO)Defense World · 2026-09-09

Latigo Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business HighlightsGlobeNewsWire · 2026-09-03

Inside Latigo Biotherapeutics' IPO: A Non-Opioid Pain Bet Goes Public24/7 Wall Street · 2026-08-13

Company Info

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

Exchange

NASDAQ

Beta

0.00

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.